Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Coagulation Factor VIII Prophylaxis in Hemophilia A
NCT04061109Phase 3Unknown
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- May 2019
- Primary completion
- Mar 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of moroctocog alfa in hemophilia A, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Status: unknown.
02
Drugs
moroctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT04061109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04061109.